2012-10-09 00:26:24 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Market Direct's pharmaceuticals report, "Basilea Pharmaceutica AG - Product Pipeline Review - 2012" provides data on the Basilea Pharmaceutica AG's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Basilea Pharmaceutica AG's corporate website, SEC filings, investor presentations and featured press releases, both from Basilea Pharmaceutica AG and industry-specific third party sources, put together by Global Markets Direct's team.


Full Report Details at
- www.fastmr.com/prod/468668_basilea_pharmaceutica_ag_product_pipe ..


Scope

* Basilea Pharmaceutica AG - Brief Basilea Pharmaceutica AG overview including business description, key

information and facts, and its locations and subsidiaries.
* Review of current pipeline of Basilea Pharmaceutica AG human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Basilea Pharmaceutica AG with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Basilea Pharmaceutica AG's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Reasons to buy

* Evaluate Basilea Pharmaceutica AG's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Basilea Pharmaceutica AG in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Basilea Pharmaceutica AG's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Basilea Pharmaceutica AG.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Basilea Pharmaceutica AG and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Basilea Pharmaceutica AG Snapshot
Basilea Pharmaceutica AG Overview
Key Information
Key Facts
Basilea Pharmaceutica AG - Research and Development Overview
Key Therapeutic Areas
Basilea Pharmaceutica AG - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Basilea Pharmaceutica AG - Pipeline Products Glance
Basilea Pharmaceutica AG - Late Stage Pipeline
Registration Filed Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Basilea Pharmaceutica AG Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
Basilea Pharmaceutica AG - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Basilea Pharmaceutica AG - Drug Profiles
BAL-101553
Product Description
Mechanism of Action
R&D Progress
BAL-27862
Product Description
Mechanism of Action
R&D Progress
BAL-30072
Product Description
Mechanism of Action
R&D Progress
BAL30072
Product Description
Mechanism of Action
R&D Progress
ceftobiprole medocaril
Product Description
Mechanism of Action
R&D Progress
Exploratory Projects For Antibiotics
Product Description
Mechanism of Action
R&D Progress
Exploratory Projects For Oncology
Product Description
Mechanism of Action
R&D Progress
isavuconazole
Product Description
Mechanism of Action
R&D Progress
Basilea Pharmaceutica AG - Pipeline Analysis
Basilea Pharmaceutica AG - Pipeline Products by Therapeutic Class
Basilea Pharmaceutica AG - Pipeline Products by Route of Administration
Basilea Pharmaceutica AG - Pipeline Products By Mechanism of Action
Basilea Pharmaceutica AG - Recent Pipeline Updates
Basilea Pharmaceutica AG - Dormant Projects
Basilea Pharmaceutica AG - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
BAL-2299
Basilea Pharmaceutica AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Basilea Pharmaceutica AG, Recent Developments
Basilea Pharmaceutica AG- Press Release
Jul 30, 2012: Basilea Pharma Submits European Marketing Authorization Application Of Ceftobiprole For Treatment Of Pneumonia
Apr 04, 2012: Basilea Presents New Research Data On Biomarker For BAL101553 At AACR
Jan 05, 2012: Basilea To File Application For Marketing Authorization Of Ceftobiprole For Treatment Of Pneumonia
Dec 30, 2009: Basilea Receives Complete Response Letter From FDA On Ceftobiprole For The Treatment Of Skin And Skin Structure Infections
Nov 19, 2009: Basilea Presents New Research Data On Oncology Drug Candidate BAL27862 At International Cancer Conference
Sep 15, 2009: Basilea Presents Data On Novel Antibiotic Compound BAL30072
May 18, 2009: Basilea Presents New Efficacy Data On BAL30072, Its Novel Antibiotic Against Gram-Negative Bacteria
Mar 06, 2009: Basilea Presents Research Data On BAL30072 At The Anti-Infectives Partnering & Deal-Making Summit
Financial Deals Landscape
Basilea Pharmaceutica AG, Deals Summary

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468668&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.